ArticleJournal of patient-reported outcomes2026
Caregiver-perceived behavioral challenges in fragile X syndrome and implications for measuring treatment benefit in clinical trials.
Article in Journal of patient-reported outcomes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03614663 (A Randomized, Double-Blind, Placebo-Controlled Multiple-Center, Efficacy and Safety Study of ZYN002 Administered as a Transdermal Gel to Children and Adolescents With Fragile X Syndrome), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
A Randomized, Double-Blind, Placebo-Controlled Multiple-Center, Efficacy and Safety Study of ZYN002 Administered as a Transdermal Gel to Children and Adolescents With Fragile X Syndrome
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundFragile X Syndrome (FXS) is a rare X-linked genetic condition. Children with FXS exhibit a variety of challenging behaviors such as irritability, anxiety, and preference for solitary activities. The Aberrant Behavior Checklist-Community (ABC-C) is an observer-reported outcome (ObsRO) measure that captures many of the behavioral concerns (e.g., outbursts, social anxiety, difficulty connecting with others) salient to caregivers of individuals with FXS. An FXS-specific scoring algorithm of the ABC-C, considered more representative of the FXS phenotype (ABC-CFXS), has been included in numerous clinical studies of treatments for FXS. The goal of this qualitative research was to establish the content validity of the ABC-CFXS domain structure in parents/caregivers of children with FXS and determine whether it is fit-for-purpose for measuring treatment benefit in clinical studies of FXS.
methodsThe qualitative data came from 3 sources: (1) Concept elicitation (CE) interviews with caregivers of children with FXS (N = 10); (2) Caregiver survey (CS) (N = 212) completed at entry to CONNECT-FX (NCT03614663); and (3) Cognitive interviews of the ABC-CFXS with caregivers of children with FXS (N = 25). Qualitative coding and analysis were consistent with best practices and followed principles in applied thematic (content) analysis. Item comprehension and relevancy of the ABC-CFXS were also examined based on data from cognitive interviews.
resultsThe mean age of individuals with FXS was 10 (range 3–17) years and was consistent across the 3 data sources. The most frequently reported behavioral challenges described by caregivers were generally consistent across the CE interviews and the CS. Socially avoidant behaviors were most prevalent (70% and 49%, respectively) followed by socially unresponsive/lack of interaction (60% and 51%, respectively) and aggression (60% and 43%, respectively). Saturation of behavioral challenges related to FXS was reached in both the CE interviews and CS and was consistent with the content of the ABC-CFXS. Cognitive interviews showed that caregivers could understand and interpret the content and response options of the ABC-CFXS and deemed its content relevant to their experience.
conclusionsThe content validity evidence from this qualitative research supports the use of ABC-CFXS as an efficacy measure in FXS clinical research studies. CLINICAL
trial registrationNot applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.